DAX19.917 -0,3%ESt504.870 -0,2%Top 10 Crypto15,12 +0,1%Dow43.114 +1,8%Nas19.715 +1,8%Bitcoin92.507 -2,0%Euro1,0428 +0,6%Öl72,79 +0,2%Gold2.625 +1,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 Novo Nordisk A3EU6F MicroStrategy 722713 Rheinmetall 703000 Volkswagen (VW) vz. 766403 Amazon 906866 Bayer BAY001 Palantir A2QA4J Apple 865985 Siemens Energy ENER6Y Deutsche Bank 514000 Mercedes-Benz Group (ex Daimler) 710000 Allianz 840400 RWE 703712
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Großer Verfallstag: DAX geht tiefer ins Wochenende -- Novo Nordisk-Therapie enttäuscht in Studie -- Bitcoin fällt tief -- Covestro fliegt aus dem DAX -- D-Wave, FedEx im Fokus
Top News
BÖRSE AKTUELL: DAX geht tiefer ins Wochenende - 20.000er-Marke rückt aus dem Blickfeld - Großer Verfallstag an der Börse BÖRSE AKTUELL: DAX geht tiefer ins Wochenende - 20.000er-Marke rückt aus dem Blickfeld - Großer Verfallstag an der Börse
Eurokurs etwas erholt - Das sind die Gründe Eurokurs etwas erholt - Das sind die Gründe
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
LAST MINUTE GESCHENK mit Herz und Verstand: Der FLEXINVEST JUNIOR-SPARPLAN. Hier KOSTENLOS abschließen & bis zu 75 € Amazon.de* Gutscheine erhalten!

Novo Nordisk Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
81,54 EUR -18,01 EUR -18,09 %
STU
79,20 EUR -20,10 EUR -20,24 %
GVIE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.439,73 Mrd. EUR

KGV37,40Div. Rendite1,35%

WKNA3EU6F

ISINDK0062498333

SymbolNONOF

Novo Nordisk Aktien News

DatumMeistgelesen
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireTrading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk conducts a two-for-one stock split
GlobeNewswireNovo Nordisk A/S - share repurchase programme
PR NewswireCanadian Investment Regulatory Organization Trading Halt - NVO.WT
PR NewswireCanadian Investment Regulatory Organization Trading Halt - NVO.WT
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswireNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
MyDividendsNovo Nordisk erhöht die Zwischendividende
GlobeNewswireNovo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
GlobeNewswireNovo Nordisk's sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk invests DKK 15.9 bn in expansion of manufacturing facilities in Hillerød, Denmark
GlobeNewswireNovo Nordisk A/S – Share repurchase programme
GlobeNewswireNovo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares
GlobeNewswireNovo Nordisk A/S - share repurchase programme
GlobeNewswireNovo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases

Novo Nordisk News

Novo Nordisk News: auf dieser Seite finden Sie alle Novo Nordisk News und Nachrichten zur Novo Nordisk Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.